Zi Long Qian
Algemeen Directeur bij SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.
Vermogen: 177 726 $ op 30-04-2024
Actieve functies van Zi Long Qian
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Algemeen Directeur | 28-10-2022 | - |
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
 Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Directeur/Bestuurslid | - | - |
Loopbaan van Zi Long Qian
Opleiding van Zi Long Qian
| China University of Geosciences | Undergraduate Degree |
| Sun Yat-Sen University | Masters Business Admin |
Statistieken
Internationaal
| China | 5 |
Operationeel
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
| Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Health Technology |
- Beurs
- Insiders
- Zi Long Qian
- Ervaring
